Metabolic Landscape of Osteosarcoma: Reprogramming of Lactic Acid Metabolism and Metabolic Communication.

lactic acid metabolism metabolic communication metabolic reprogramming osteosarcoma

Journal

Frontiers in bioscience (Landmark edition)
ISSN: 2768-6698
Titre abrégé: Front Biosci (Landmark Ed)
Pays: Singapore
ID NLM: 101612996

Informations de publication

Date de publication:
22 Feb 2024
Historique:
received: 09 08 2023
revised: 30 09 2023
accepted: 12 10 2023
medline: 29 2 2024
pubmed: 29 2 2024
entrez: 29 2 2024
Statut: ppublish

Résumé

Lactic acid, previously regarded only as an endpoint of glycolysis, has emerged as a major regulator of tumor invasion, growth, and the tumor microenvironment. In this study, we aimed to explore the reprogramming of lactic acid metabolism relevant to osteosarcoma (OS) microenvironment by decoding the underlying lactic acid metabolic landscape of OS cells and intercellular signaling alterations. The landscape of OS metabolism was evaluated using single-cell gene expression data, lactic acid metabolism clustering, and screening of the hub genes in lactic acid metabolism of OS samples using transcriptome data. The role of the hub gene NADH:Ubiquinone Oxidoreductase Complex Assembly Factor 6 ( Single-cell RNA sequencing data validated a lactic acid metabolismhigh subcluster in OS. Further investigation of intercellular communications revealed a unique metabolic communication pattern between the lactic acid metabolismhigh subcluster and other subclusters. Next, two lactic acid metabolic reprogramming phenotypes were defined, and six lactic acid metabolism-related genes (LRGs), including the biomarker The patterns of lactic acid metabolism in OS suggested metabolic reprogramming phenotypes relevant to the tumor microenvironment (TME) and identified

Sections du résumé

BACKGROUND BACKGROUND
Lactic acid, previously regarded only as an endpoint of glycolysis, has emerged as a major regulator of tumor invasion, growth, and the tumor microenvironment. In this study, we aimed to explore the reprogramming of lactic acid metabolism relevant to osteosarcoma (OS) microenvironment by decoding the underlying lactic acid metabolic landscape of OS cells and intercellular signaling alterations.
METHODS METHODS
The landscape of OS metabolism was evaluated using single-cell gene expression data, lactic acid metabolism clustering, and screening of the hub genes in lactic acid metabolism of OS samples using transcriptome data. The role of the hub gene NADH:Ubiquinone Oxidoreductase Complex Assembly Factor 6 (
RESULTS RESULTS
Single-cell RNA sequencing data validated a lactic acid metabolismhigh subcluster in OS. Further investigation of intercellular communications revealed a unique metabolic communication pattern between the lactic acid metabolismhigh subcluster and other subclusters. Next, two lactic acid metabolic reprogramming phenotypes were defined, and six lactic acid metabolism-related genes (LRGs), including the biomarker
CONCLUSIONS CONCLUSIONS
The patterns of lactic acid metabolism in OS suggested metabolic reprogramming phenotypes relevant to the tumor microenvironment (TME) and identified

Identifiants

pubmed: 38420794
pii: S2768-6701(23)01076-6
doi: 10.31083/j.fbl2902083
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

83

Subventions

Organisme : Beijing Municipal Science & Technology Commission, Administrative Commission of Zhongguancun Science Park
ID : Z191100007619023
Organisme : National Natural Science Foundation of China
ID : 8197210
Organisme : National Natural Science Foundation of China
ID : 82372451

Informations de copyright

© 2024 The Author(s). Published by IMR Press.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Auteurs

Linbang Wang (L)

Department of Orthopedics, Peking University Third Hospital, 100191 Beijing, China.
Beijing Key Laboratory of Spinal Disease Research, 100191 Beijing, China.
Engineering Research Center of Bone and Joint Precision Medicine, Ministry of Education, 100191 Beijing, China.

Xinyu Dou (X)

Department of Orthopedics, Peking University Third Hospital, 100191 Beijing, China.
Beijing Key Laboratory of Spinal Disease Research, 100191 Beijing, China.
Engineering Research Center of Bone and Joint Precision Medicine, Ministry of Education, 100191 Beijing, China.

Linzhen Xie (L)

Peking University Fourth School of Clinical Medicine, 100035 Beijing, China.

Xuchang Zhou (X)

School of Sport Medicine and Rehabilitation, Beijing Sport University, 100084 Beijing, China.

Yu Liu (Y)

Department of Orthopedics, Peking University Third Hospital, 100191 Beijing, China.
Beijing Key Laboratory of Spinal Disease Research, 100191 Beijing, China.
Engineering Research Center of Bone and Joint Precision Medicine, Ministry of Education, 100191 Beijing, China.

Jingkun Liu (J)

Department of Orthopedics, Honghui Hospital, Xi'an Jiaotong University, 710054 Xi'an, Shaanxi, China.

Xiaoguang Liu (X)

Department of Orthopedics, Peking University Third Hospital, 100191 Beijing, China.
Beijing Key Laboratory of Spinal Disease Research, 100191 Beijing, China.
Engineering Research Center of Bone and Joint Precision Medicine, Ministry of Education, 100191 Beijing, China.

Classifications MeSH